{"id":47208,"date":"2025-06-09T14:01:18","date_gmt":"2025-06-09T21:01:18","guid":{"rendered":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/?p=47208"},"modified":"2025-06-09T14:02:20","modified_gmt":"2025-06-09T21:02:20","slug":"nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements","status":"publish","type":"post","link":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/","title":{"rendered":"NM attorney general and two manufacturers cap diabetes drug costs in settlements"},"content":{"rendered":"\n<p class=\"has-text-align-left has-background\" style=\"background-color:#8080801f\"><em><strong>This <a href=\"https:\/\/sourcenm.com\/briefs\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/\">story<\/a> was originally published at <a href=\"https:\/\/sourcenm.com\/\">Source New Mexico<\/a>, a NMPBS partner.<\/strong><\/em><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg\" alt=\"Close-up of three insulin pens with needles exposed, showing different colors and dose dials, placed side by side on a white surface.\" class=\"wp-image-47210\" srcset=\"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg 1920w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-300x169.jpg 300w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-1024x576.jpg 1024w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-1536x864.jpg 1536w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-24x14.jpg 24w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-36x20.jpg 36w, https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles-48x27.jpg 48w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><figcaption class=\"wp-element-caption\">Image by Canva.<\/figcaption><\/figure>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\"><\/div>\n<\/div>\n\n\n\n<p>By Austin Fisher, Source New Mexico<\/p>\n\n\n\n<p>Under settlement agreements reached earlier this year and announced by New Mexico Attorney General Ra\u00fal Torrez on Wednesday, two insulin manufacturers have committed to make the diabetes treatment cheaper for New Mexicans.<\/p>\n\n\n\n<p>\u201cThese are huge wins for New Mexicans who have struggled with the outrageous cost of insulin,\u201d Torrez said in a statement. \u201cThese agreements will help people stop rationing medication, avoid financial hardship, and focus on staying healthy. We are holding drug manufacturers accountable and making access to life-saving treatment more equitable.\u201d<\/p>\n\n\n\n<p>New Mexico Department of Justice spokesperson Lauren Rodriguez told Source NM that the agreements provide insured patients who might have a high deductible or copay the option to pay cash instead of using their insurance, and to pay no more than $35 for a monthly supply of insulin, Rodriguez said.<\/p>\n\n\n\n<p>The New Mexico <a href=\"https:\/\/www.nmlegis.gov\/Legislation\/Legislation?Chamber=H&amp;LegType=B&amp;LegNo=292&amp;year=20\">state law<\/a> enacted in 2020 that caps insulin costs at $25 remains in full force and is not preempted or replaced by the new settlements, Rodriguez said.<\/p>\n\n\n\n<p>Instead, the agreements are \u201cadditive protections mainly aimed at helping cash-paying and uninsured patients, while deferring to state law when it offers better pricing,\u201d she said.<\/p>\n\n\n\n<p>As many as 207,600 adults in New Mexico, or approximately 11% of the state\u2019s adult population, have diabetes, <a href=\"https:\/\/diabetes.org\/sites\/default\/files\/2025-04\/state-fact-sheet-4-15-25-new-mexico.pdf\">according<\/a> to the American Diabetes Association.<\/p>\n\n\n\n<p>Without the caps, patients in other states could pay $150 per month or more, especially if they require multiple variations of the drug, Stateline <a href=\"https:\/\/sourcenm.com\/2023\/01\/13\/more-states-are-doing-what-they-can-to-cap-insulin-costs\/\">reports.<\/a><\/p>\n\n\n\n<p>High out-of-pocket costs have historically forced many patients to choose between buying insulin and meeting other basic needs, NMDOJ said in a news release. The settlements result from the agency\u2019s independent investigations into insulin pricing practices, NMDOJ said.<\/p>\n\n\n\n<p>The state\u2019s agreement with Sanofi-Aventis U.S. LLC, signed on April 18, requires the company to maintain its Insulins ValYou Savings Program, which allows patients who pay out-of-pocket to receive a month\u2019s supply for $35.<\/p>\n\n\n\n<p>The Sanofi settlement also requires it to maintain its Patient Connection Program, which allows uninsured patients who aren\u2019t eligible for Medicaid and whose annual household income is at or below 400% of the federal poverty line to receive insulin for free.<\/p>\n\n\n\n<p>Under the settlement, Sanofi must also provide patients live phone and translation support in Spanish, Hmong, Somali and Mandarin Chinese; and participating pharmacies will receive training to help patients enroll in affordability programs.<\/p>\n\n\n\n<p>The settlement with Novo Nordisk Inc., signed on May 19, requires the company to maintain its MyInsulinRX Program, which offers diabetes patients the option to pay $35 or less for a monthly prescription. Under the agreement, Novo Nordisk must also continue its Patient Assistance Program, which offers insulin for free.<\/p>\n\n\n\n<p>The settlement also requires Novo Nordisk to notify pharmacies about available discounts at the point of sale, help patients enroll on the spot and offer live phone and website chat support in Spanish.<\/p>\n\n\n\n<p><em>Reporter Danielle Prokop contributed reporting to this story.<\/em><\/p>\n\n\n\n<p><em>This story was originally published at <a href=\"https:\/\/sourcenm.com\/\">Source New Mexico<\/a>, a NMPBS partner.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This story was originally published at Source New Mexico, a NMPBS partner. By Austin Fisher, Source New Mexico Under settlement agreements reached earlier this year and announced by New Mexico Attorney General Ra\u00fal Torrez on Wednesday, two insulin manufacturers have committed to make the diabetes treatment cheaper for New Mexicans. \u201cThese are huge wins for&hellip;<\/p>\n","protected":false},"author":45,"featured_media":47210,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10906],"tags":[10907],"class_list":["post-47208","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partner-stories","tag-partner-stories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus\" \/>\n<meta property=\"og:description\" content=\"This story was originally published at Source New Mexico, a NMPBS partner. By Austin Fisher, Source New Mexico Under settlement agreements reached earlier this year and announced by New Mexico Attorney General Ra\u00fal Torrez on Wednesday, two insulin manufacturers have committed to make the diabetes treatment cheaper for New Mexicans. \u201cThese are huge wins for&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/\" \/>\n<meta property=\"og:site_name\" content=\"New Mexico In Focus\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T21:01:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-09T21:02:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Austin Fisher, Source New Mexico\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Austin Fisher, Source New Mexico\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/\"},\"author\":{\"name\":\"Austin Fisher, Source New Mexico\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/#\\\/schema\\\/person\\\/3e35f871845f36ccf0e15f23c4e8e117\"},\"headline\":\"NM attorney general and two manufacturers cap diabetes drug costs in settlements\",\"datePublished\":\"2025-06-09T21:01:18+00:00\",\"dateModified\":\"2025-06-09T21:02:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/\"},\"wordCount\":516,\"image\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Generic-insulin-needles.jpg\",\"keywords\":[\"Partner Stories\"],\"articleSection\":[\"Partner Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/\",\"url\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/\",\"name\":\"NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Generic-insulin-needles.jpg\",\"datePublished\":\"2025-06-09T21:01:18+00:00\",\"dateModified\":\"2025-06-09T21:02:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/#\\\/schema\\\/person\\\/3e35f871845f36ccf0e15f23c4e8e117\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Generic-insulin-needles.jpg\",\"contentUrl\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Generic-insulin-needles.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Image by Canva.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NM attorney general and two manufacturers cap diabetes drug costs in settlements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/#website\",\"url\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/\",\"name\":\"New Mexico In Focus\",\"description\":\"Involved, Informed, In-depth Journalism\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/#\\\/schema\\\/person\\\/3e35f871845f36ccf0e15f23c4e8e117\",\"name\":\"Austin Fisher, Source New Mexico\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g\",\"caption\":\"Austin Fisher, Source New Mexico\"},\"url\":\"https:\\\/\\\/www.newmexicopbs.org\\\/productions\\\/newmexicoinfocus\\\/author\\\/austinfisher\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/","og_locale":"en_US","og_type":"article","og_title":"NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus","og_description":"This story was originally published at Source New Mexico, a NMPBS partner. By Austin Fisher, Source New Mexico Under settlement agreements reached earlier this year and announced by New Mexico Attorney General Ra\u00fal Torrez on Wednesday, two insulin manufacturers have committed to make the diabetes treatment cheaper for New Mexicans. \u201cThese are huge wins for&hellip;","og_url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/","og_site_name":"New Mexico In Focus","article_published_time":"2025-06-09T21:01:18+00:00","article_modified_time":"2025-06-09T21:02:20+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg","type":"image\/jpeg"}],"author":"Austin Fisher, Source New Mexico","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Austin Fisher, Source New Mexico","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#article","isPartOf":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/"},"author":{"name":"Austin Fisher, Source New Mexico","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/#\/schema\/person\/3e35f871845f36ccf0e15f23c4e8e117"},"headline":"NM attorney general and two manufacturers cap diabetes drug costs in settlements","datePublished":"2025-06-09T21:01:18+00:00","dateModified":"2025-06-09T21:02:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/"},"wordCount":516,"image":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#primaryimage"},"thumbnailUrl":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg","keywords":["Partner Stories"],"articleSection":["Partner Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/","url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/","name":"NM attorney general and two manufacturers cap diabetes drug costs in settlements - New Mexico In Focus","isPartOf":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#primaryimage"},"image":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#primaryimage"},"thumbnailUrl":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg","datePublished":"2025-06-09T21:01:18+00:00","dateModified":"2025-06-09T21:02:20+00:00","author":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/#\/schema\/person\/3e35f871845f36ccf0e15f23c4e8e117"},"breadcrumb":{"@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#primaryimage","url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg","contentUrl":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-content\/uploads\/2025\/06\/Generic-insulin-needles.jpg","width":1920,"height":1080,"caption":"Image by Canva."},{"@type":"BreadcrumbList","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/nm-attorney-general-and-two-manufacturers-cap-diabetes-drug-costs-in-settlements\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/"},{"@type":"ListItem","position":2,"name":"NM attorney general and two manufacturers cap diabetes drug costs in settlements"}]},{"@type":"WebSite","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/#website","url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/","name":"New Mexico In Focus","description":"Involved, Informed, In-depth Journalism","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/#\/schema\/person\/3e35f871845f36ccf0e15f23c4e8e117","name":"Austin Fisher, Source New Mexico","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa2fede2746e8e48da3739421e1ba548d8301edec7cf87ba224f19584bd53a0f?s=96&d=mm&r=g","caption":"Austin Fisher, Source New Mexico"},"url":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/author\/austinfisher\/"}]}},"_links":{"self":[{"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/posts\/47208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/comments?post=47208"}],"version-history":[{"count":1,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/posts\/47208\/revisions"}],"predecessor-version":[{"id":47211,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/posts\/47208\/revisions\/47211"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/media\/47210"}],"wp:attachment":[{"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/media?parent=47208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/categories?post=47208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newmexicopbs.org\/productions\/newmexicoinfocus\/wp-json\/wp\/v2\/tags?post=47208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}